Family Offices Increase Deal Activity in Biotech Sector
TL;DR Summary
In June, family offices increased their investment activity, making 60 direct investments, particularly in biotech and healthcare firms like Antheia, driven by a desire for impactful and profitable scientific breakthroughs, leveraging their patient capital.
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
62%
89 → 34 words
Want the full story? Read the original article
Read on CNBC